Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®
Go back to Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®| Pfizer Inc. (NYSE: PFE) | Delayed: 27.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.79 | 52 Week Low | $28.25 | |||
| Day High | $27.79 | P/E | 16.84 | |||
| Day Low | $27.79 | EPS | $1.65 | |||
| Volume | 34,115 | |||||

